Is Viking Therapeutics Stock Really Heading Higher
Investors often chase big biotech gains, but Viking Therapeutics stock really hinges on milestones and cash runway. T...
Discover what to know about cash back and taxes to manage your finances better. Stay informed and make wise decisions.
28,655 articlesInvestors often chase big biotech gains, but Viking Therapeutics stock really hinges on milestones and cash runway. T...
IP Strategy said its board approved a buyback of up to 1,000,000 common shares through Dec. 31, 2026, potentially tri...
Could buying sweetgreen stock be a gateway to lasting wealth, or is it a risky turnaround bet? This guide cuts throug...
A blockbuster SpaceX IPO sparks a midday rally as AI optimism and falling oil prices lift major indices. This guide b...
Public disclosures show intriguing shifts in a high-profile portfolio. This article breaks down what it means when pr...
Berkshire Hathaway reduced its cash hoard to $373.3 billion by year-end 2025, a 2.1% drop from September, as Greg Abe...
Opendoor expands its cash-offer toolkit through a RealScout integration, framing it as opendoor’s ‘grand reopening’: ...
Broadcom is signaling strong momentum in AI infrastructure with a growing portfolio of custom chips and a robust back...
Tesla isn’t just selling cars—it's building an autonomy and energy ecosystem. This piece examines whether tesla: wall...
As markets digest a potential shift in leadership, the biggest test for any Fed chair may be broader than inflation. ...
Duolingo is quietly reshaping its AI approach to learning. This piece explains why the duolingo most interesting play...
A massive compute deal rumor could redraw the AI cloud map. This article explains what the potential billion compute ...